Keren Armoni Domany1,2, Sumalee Hantragool1,3, David F Smith1,4,5, Yuanfang Xu6, Monir Hossain6, Narong Simakajornboon1. 1. Division of Pulmonary and Sleep Medicine, Cincinnati Children's Hospital, Cincinnati, Ohio. 2. Department of Pediatric Pulmonology, Critical Care and Sleep Medicine, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel. 3. Division of Pulmonology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 4. Division of Pediatric Otolaryngology - Head and Neck Surgery, Cincinnati Children's Hospital, Cincinnati, Ohio. 5. Department of Otolaryngology - Head and Neck Surgery, University of Cincinnati School of Medicine, Cincinnati, Ohio. 6. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Abstract
STUDY OBJECTIVES: The nature of sleep disorders in children with Ehlers-Danlos syndrome (EDS) is unknown. We aimed to describe the type, the management, and the short-term outcome of sleep disorders in children with EDS referred to sleep clinics. METHODS: This is a retrospective review of medical records and polysomnography tests of children with EDS younger than 18 years who were referred to the sleep clinic. Demographic information and medical history were collected, and polysomnography tests were reviewed. Questionnaires completed during previous clinic visits, including the Pediatrics Sleep Questionnaire (PSQ), Epworth Sleepiness Scale (ESS), and Pediatric Quality of Life Inventory (PedsQL), were also evaluated. RESULTS: Sixty-five patients with EDS-hypermobility type were included. The mean age was 13.15 ± 3.9 years. There were 68% of patients who were female, and 91% of patients were Caucasian. The mean follow-up period was 1.14 ± 1.55 years. Common sleep diagnoses included insomnia (n = 14, 22%), obstructive sleep apnea (OSA) (n = 17, 26%), periodic limb movement disorder (PLMD) (n = 11, 17%), and hypersomnia (n = 10, 15%). In addition, 65% required pharmacologic treatment and 29% were referred to behavioral sleep medicine. For OSA, two patients required continuous positive airway pressure. A significant improvement was observed in the PSQ, ESS, and PedsQL scores during follow-up visits after treatment (n = 34; P = .0004, 0.03, and 0.01, respectively). CONCLUSIONS: There is a high prevalence of sleep disorders, including OSA, insomnia, PLMD, and hypersomnia in children with EDS referred to sleep clinics. Specific management can improve quality of life and questionnaire scores of this patient population. Our study emphasizes the importance of screening for sleep disorders in children with EDS.
STUDY OBJECTIVES: The nature of sleep disorders in children with Ehlers-Danlos syndrome (EDS) is unknown. We aimed to describe the type, the management, and the short-term outcome of sleep disorders in children with EDS referred to sleep clinics. METHODS: This is a retrospective review of medical records and polysomnography tests of children with EDS younger than 18 years who were referred to the sleep clinic. Demographic information and medical history were collected, and polysomnography tests were reviewed. Questionnaires completed during previous clinic visits, including the Pediatrics Sleep Questionnaire (PSQ), Epworth Sleepiness Scale (ESS), and Pediatric Quality of Life Inventory (PedsQL), were also evaluated. RESULTS: Sixty-five patients with EDS-hypermobility type were included. The mean age was 13.15 ± 3.9 years. There were 68% of patients who were female, and 91% of patients were Caucasian. The mean follow-up period was 1.14 ± 1.55 years. Common sleep diagnoses included insomnia (n = 14, 22%), obstructive sleep apnea (OSA) (n = 17, 26%), periodic limb movement disorder (PLMD) (n = 11, 17%), and hypersomnia (n = 10, 15%). In addition, 65% required pharmacologic treatment and 29% were referred to behavioral sleep medicine. For OSA, two patients required continuous positive airway pressure. A significant improvement was observed in the PSQ, ESS, and PedsQL scores during follow-up visits after treatment (n = 34; P = .0004, 0.03, and 0.01, respectively). CONCLUSIONS: There is a high prevalence of sleep disorders, including OSA, insomnia, PLMD, and hypersomnia in children with EDS referred to sleep clinics. Specific management can improve quality of life and questionnaire scores of this patient population. Our study emphasizes the importance of screening for sleep disorders in children with EDS.
Authors: Alan Hakim; Inge De Wandele; Chris O'Callaghan; Alan Pocinki; Peter Rowe Journal: Am J Med Genet C Semin Med Genet Date: 2017-02-10 Impact factor: 3.908
Authors: Thomas Gaisl; Cecilia Giunta; Daniel J Bratton; Kate Sutherland; Christian Schlatzer; Noriane Sievi; Daniel Franzen; Peter A Cistulli; Marianne Rohrbach; Malcolm Kohler Journal: Thorax Date: 2017-01-10 Impact factor: 9.139
Authors: Mark C Scheper; Lesley L Nicholson; Roger D Adams; Louise Tofts; Verity Pacey Journal: Rheumatology (Oxford) Date: 2017-12-01 Impact factor: 7.580
Authors: Carole L Marcus; Lee Jay Brooks; Kari A Draper; David Gozal; Ann Carol Halbower; Jacqueline Jones; Michael S Schechter; Sally Davidson Ward; Stephen Howard Sheldon; Richard N Shiffman; Christopher Lehmann; Karen Spruyt Journal: Pediatrics Date: 2012-08-27 Impact factor: 7.124
Authors: Daniel L Picchietti; Oliviero Bruni; Al de Weerd; Jeffrey S Durmer; Suresh Kotagal; Judith A Owens; Narong Simakajornboon Journal: Sleep Med Date: 2013-09-04 Impact factor: 3.492
Authors: Yusuf Patrick; Alice Lee; Oishik Raha; Kavya Pillai; Shubham Gupta; Sonika Sethi; Felicite Mukeshimana; Lothaire Gerard; Mohammad U Moghal; Sohag N Saleh; Susan F Smith; Mary J Morrell; James Moss Journal: Sleep Biol Rhythms Date: 2017-04-13 Impact factor: 1.186
Authors: Mara Lelii; Elena Baggi; Laura Senatore; Maria Francesca Bedeschi; Robertino Dilena; Maria Iascone; Silvana Gangi; Paola Marchisio; Maria Francesca Patria Journal: J Pediatr Genet Date: 2019-10-21
Authors: Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris Journal: Dev Dyn Date: 2020-08-17 Impact factor: 3.780